Bromodeoxyuridine (BrdU)

For research use only.

Catalog No.S7918 Synonyms: 5-Bromo-2'-deoxyuridine, BUdR

8 publications

Bromodeoxyuridine (BrdU) Chemical Structure

CAS No. 59-14-3

Bromodeoxyuridine (BrdU, 5-Bromo-2'-deoxyuridine, BUdR) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.

Selleck's Bromodeoxyuridine (BrdU) has been cited by 8 publications

3 Customer Reviews

  • Immunofluorescence microphotographs of proliferating ARPE-19 cell with BrdU (red) and DAPI (blue) staining after ARPE-19 cells were untreated or treated with AF (1.0 μM) in the absence or presence of EGF (100ng/ml) for 24 hours and then subjected to BrdU labeling for 4 hours, followed by immunostaining with anti-BrdU antibody and DAPI. Scale bar = 20μm.

    PLoS One, 2016, 11(11):e0166386.. Bromodeoxyuridine (BrdU) purchased from Selleck.

    Immunofluorescence microphotographs of proliferating ARPE-19 cell with BrdU (red) and DAPI (blue) staining after ARPE-19 cells were untreated or treated with AF (1.0 μM) in the absence or presence of EGF (100ng/ml) for 24 hours and then subjected to BrdU labeling for 4 hours, followed by immunostaining with anti-BrdU antibody and DAPI. Scale bar = 20μm.

    PLoS One, 2016, 11(11):e0166386. Bromodeoxyuridine (BrdU) purchased from Selleck.

  • Immunofluorescence microphotographs of proliferating ARPE-19 cells with BrdU (red) and DAPI (blue) staining were taken after ARPE-19 cells were left untreated or treated with H2O2 (300 µmol/L) in the absence or presence of EGF (100 ng/mL) for 24h and then subjected to BrdU labeling for 4h, followed by immunostaining with anti-BrdU antibody and DAPI.

    Int J Ophthalmol, 2017, 10(4):507-514. Bromodeoxyuridine (BrdU) purchased from Selleck.

Purity & Quality Control

Choose Selective DNA/RNA Synthesis Inhibitors

Biological Activity

Description Bromodeoxyuridine (BrdU, 5-Bromo-2'-deoxyuridine, BUdR) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.
In vitro

In RG2 rat glioma cells, Bromodeoxyuridine induces a progressive, dose-responsive suppression of cancer cell line and cancer stem cell population expansion. In H9 cells and BJ fibroblasts, Bromodeoxyuridine alters the cell cycle profile. [1] BrdU is stably integrated into the DNA, and thus can be used in assessment of cell proliferation and other cell procession. [2]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
mouse neural precursor cells MXnBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MVjBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IH3veZNmKG6ndYLhcEBxemWldYLzc5Ih[2WubIOgZpkhVVSWIHHzd4F6NCCHQ{WwQVIvODR3zszN NEj5WZU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{SxO|Y{OSd-MUe0NVc3OzF:L3G+
murine leukemia cells NETNOJJIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NVzwN257UW5idnn0do8h\3Kxd4ToJIlvcGmkaYTpc44hd2ZiRnTVdoQhemW|aYP0ZY51KEx3MUe4XU1T\XOrc4ThcpQhdXW{aX7lJIxmfWunbXnhJINmdGy|LDDJR|UxRTF{zszN MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTFyMUO1Okc,OTFzMEGzOVY9N2F-
murine leukemia cells NVz4XFg5T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NI\SfHdKdiC4aYTyc{Boem:5dHigbY5pcWKrdHnvckBw\iCONUG3PHkuWGG{ZX70ZYwhdXW{aX7lJIxmfWunbXnhJINmdGy|IHL5JIlv[2:{cH;yZZRqd25ib3[gX|E1S12OZYWuMEBKSzVyPUKw{txO M2j1cVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzMUCxN|U3Lz5zMUGwNVM2PjxxYU6=
murine leukemia cells NXfncWVUT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MlPITY4hfmm2cn:g[5Jwf3SqIHnubIljcXSrb36gc4YhVDVzN{jZMXBiemWwdHHsJI12emmwZTDs[ZVs\W2rYTDj[YxteyxiSVO1NF0zPs7:TR?= NETTNZQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUGwNVM2Pid-MUGxNFE{PTZ:L3G+
murine leukemia cells NXu1OphWT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NHPMU2JKdiC4aYTyc{Boem:5dHigbY5pcWKrdHnvckBw\iCONUG3PHkuWGG{ZX70ZYwhdXW{aX7lJIxmfWunbXnhJINmdGy|IHL5JIlv[2:{cH;yZZRqd25ib3[gX|E1S11vVHjkMkwhUUN3ME2yOu69VQ>? NWS5NGI4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUGxNFE{PTZpPkGxNVAyOzV4PD;hQi=>

... Click to View More Cell Line Experimental Data

In vivo In rat glioma RG2 tumor model, Bromodeoxyuridine (300 mg/kg, i.p. or 0.8 mg/ml, p.o.) significantly slows tumor progression. [1]

Protocol

Cell Research:[1]
- Collapse
  • Cell lines: RG2 rat glioma cells
  • Concentrations: ~ 50 µM
  • Incubation Time: 24 hours
  • Method: Cultures are initially plated at 2000 cells/cm2 and are quantified with a Z2 Coulter Counter. RG2 rat glioma cells are treated once with 0, 1, 10, or 50 µM BrdU for 24 hours, and cumulative growth curves were obtained over 18 days. Control and treated cells are quantified and replated at equal densities on days 5, 12, and 18 after treatment.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 61 mg/mL (198.63 mM)
Water Insoluble
Ethanol '2 mg/mL warmed

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 307.1
Formula

C9H11BrN2O5

CAS No. 59-14-3
Storage 3 years -20°C(in the dark) powder
2 years -80°C(in the dark) in solvent
Synonyms 5-Bromo-2'-deoxyuridine, BUdR
Smiles C1C(C(OC1N2C=C(C(=O)NC2=O)Br)CO)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04365205 Recruiting Procedure: Endobronchial biopsy Asthma University Hospital Bordeaux September 23 2020 --
NCT02654925 Completed Procedure: Adipose Tissue Biopsy Obesity University of Colorado Denver March 2016 --
NCT01407211 Unknown status Dietary Supplement: vitamin A Relapsing Remitting Multiple Sclerosis Tehran University of Medical Sciences April 2011 Phase 4
NCT01414972 Unknown status Drug: Vitamin A|Drug: placebo Atherosclerosis Tehran University of Medical Sciences May 2010 Phase 4
NCT01225289 Completed Dietary Supplement: Vitamin A|Drug: Placebo Relapsing Remitting Multiple Sclerosis Tehran University of Medical Sciences October 2009 Phase 4
NCT00032344 Completed Procedure: Colonoscopy Colorectal Cancer US Department of Veterans Affairs|VA Office of Research and Development October 1993 Phase 3

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

DNA/RNA Synthesis Signaling Pathway Map

Related DNA/RNA Synthesis Products

Tags: buy Bromodeoxyuridine (BrdU) | Bromodeoxyuridine (BrdU) supplier | purchase Bromodeoxyuridine (BrdU) | Bromodeoxyuridine (BrdU) cost | Bromodeoxyuridine (BrdU) manufacturer | order Bromodeoxyuridine (BrdU) | Bromodeoxyuridine (BrdU) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID